Browsing by Author Li, Zhiming

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 30 to 48 of 48 < previous 
Issue DateTitleAuthor(s)
15-Apr-2023The Oral PI3Kd Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical TrialWang, Tingyu; Sun, Xiuhua; Qiu, Lihua; Su, Hang; Cao, Junning; Li, Zhiming; Song, Yuqin; Zhang, Li; Li, Dengju; Wu, Huijing; Zhang, Wei; Li, Junmin; Zhou, Keshu; Zhou, Hui; Yang, Yu; Li, Zhifeng; Cen, Hong; Cai, Zhen; Zhang, Zhihui; Fu, Weijun; Jin, Jie; Li, Fei; Wu, Weixin; Gu, Xuekui; Zhu, Weiliang; Liu, Lihong; Li, Zengjun; Yi, Shuhua; Bao, Hanying; Xu, Zusheng; Qiu, Lugui
2023Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label studyDeng, Lijuan; Li, Zhiming; Zhang, Huilai; Huang, Haiwen; Hu, Jianda; Liu, Lihong; Liu, Ting; Jin, Jie; Zhu, Zunmin; Li, Wenyu; Huang, Zhenqian; Huang, Wenrong; Zhou, Keshu; Yang, Haiyan; Zhang, Mingzhi; Ding, Kaiyang; Zhou, Hui; Hu, Yu; Shuang, Yuerong; Cao, Junning; Gao, Sujun; Li, Dengju; Sun, Zimin; Zhang, Qingyuan; Yi, Shuhua; Ji, Chunyan; Zhang, Liansheng; Hou, Cheng; Du, Yue; Wang, Weige; Zhao, Renbin; Song, Yuqin; Zhu, Jun
26-Jun-2021OTOGL, a gelforming mucin protein, is nonessential for male germ cell development and spermatogenesis in miceLi, Zhiming; Zhang, Yan; Zhang, Xinzong; Cao, Congcong; Luo, Xiaomin; Gui, Yaoting; Tang, Yunge; Yuan, Shuiqiao
8-Sep-2021OTOGL, a gelforming mucin protein, is nonessential for male germ cell development and spermatogenesis in mice (vol 19, 95, 2021)Li, Zhiming; Zhang, Yan; Zhang, Xinzong; Cao, Congcong; Luo, Xiaomin; Gui, Yaoting; Tang, Yunge; Yuan, Shuiqiao
2018p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesisLi, Meiting; Hou, Tianyun; Gao, Tian; Lu, Xiaopeng; Yang, Qiaoyan; Zhu, Qian; Li, Zhiming; Liu, Chaohua; Mu, Guanqun; Liu, Ge; Bao, Yantao; Wen, He; Wang, Lina; Wang, Haiying; Zhao, Ying; Gu, Wei; Yang, Yang; Zhu, Wei-Guo
2020Parameter estimation in uncertain differential equations with exponential solutionsLi, Zhiming; Ai, Mingyao; Sun, Shuman
20-Dec-2022A population-based study of precision health assessments using multi-omics network-derived biological functional modulesZhang, Wei; Wan, Ziyun; LI, Xiaoyu; LI, Rui; Luo, Lihua; Song, Zijun; Miao, Yu; Li, Zhiming; Wang, Shiyu; Shan, Ying; Li, Yan; Chen, Bangwei; Zhen, Hefu; Sun, Yuzhe; Fang, Mingyan; Ding, Jiahong; Yan, Yizhen; Zong, Yang; Wang, Zhen; Zhang, Wenwei; Yang, Huanming; Yang, Shuang; Wang, Jian; Jin, Xin; Wang, Ru; Chen, Peijie; Min, Junxia; Zeng, Yi; Li, Tao; Xu, Xun; Nie, Chao
15-Nov-2022Preliminary Safety and Efficacy Evaluation of IMM0306, a CD47 and CD20 Bispecific Monoclonal Antibody-Trap (mAbTrap), from an Ongoing Phase I Dose-Escalation Study in Patients with Relapsed or Refractory B-Cell Non- Hodgkin's Lymphoma (R/R B-NHL)Shi, Yuankai; Song, Yongping; Zhang, Mingzhi; Jing, Hongmei; Wang, Zhen; Li, Zhiming; Qi, Junyuan; Li, Fei; Li, Wenyu; Yang, Jianliang; Gao, Siman; Ma, Huizi; He, Heming; Lu, Qiying; Tian, Wenzhi
2017Quantitative Visualization of Dynamic Tracer Transportation in the Extracellular Space of Deep Brain Regions Using Tracer-Based Magnetic Resonance ImagingHou, Jin; Wang, Wei; Quan, Xianyue; Liang, Wen; Li, Zhiming; Han, Hongbin; Chen, Deji
2014Reply to Leithner et al.: Focus on phopshoenolpyruvate carboxykinase (PEPCK): A target of the p53-SIRT6-FoxO1 axisLi, Zhiming; Zhu, Wei-Guo
Jun-2022Risk difference tests for stratified binary data under Dallal's modelSun, Shuman; Li, Zhiming; Ai, Mingyao; Jiang, Haijun
5-Nov-2024Safety and Preliminary Efficacy of F0002, an Anti-CD30 Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-1 or PD-L1 Therapy: Results from F0002-101 Phase 1 StudySong, Yuqin; Yin, Qingsong; Li, Zhiming; Meng, Jingye; Yan, Yan; Zhou, Mengli; Sun, Wenyi; Liu, Kezhen; Zhu, Jun
2019SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repairTang, Ming; Li, Zhiming; Zhang, Chaohua; Lu, Xiaopeng; Tu, Bo; Cao, Ziyang; Li, Yinglu; Chen, Yongcan; Jiang, Lu; Wang, Hui; Wang, Lina; Wang, Jiadong; Liu, Baohua; Xu, Xingzhi; Wang, Haiying; Zhu, Wei-Guo
2019A specific assay for JmjC domain-containing lysine demethylase and its application to inhibitor screeningWen, He; Li, Guo; Chen, Yongcan; Li, Meiting; Lv, Yafei; Li, Zhiming; Li, Yinglu; Hou, Tianyun; Wang, Hui; Liu, Chaohua; Lu, Xiaopeng; Zhu, Qian; Bao, Yantao; Liu, Ge; Li, Xiaofan; Zhu, Wei-Guo
30-Nov-2020Statistical tests under Dallal's model: Asymptotic and exact methodsLi, Zhiming; Ma, Changxing; Ai, Mingyao
2004Study on casing loads in creep formationsYin, Youquan; Li, Zhiming; Zhang, Guangqing; Zhang, Xingchao
2014Targeting Histone Deacetylases for Cancer Therapy: From Molecular Mechanisms to Clinical ImplicationsLi, Zhiming; Zhu, Wei-Guo
26-Sep-2024Time to lymphoma treatment within 24 months in 'watch and wait' follicular lymphoma is associated with inferior outcomes: A multicentre analysisLiu, Jing; Gao, Fenghua; Zhang, Tingting; Wang, Jiesong; Li, Zhiming; Liu, Lihong; Zhou, Hui; Zhang, Xudong; Sun, Xiuhua; Zhang, Wei; Xu, Bing; Su, Liping; Wen, Shujuan; Tao, Rong; Bai, Ou; Zou, Liqun; Li, Lanfang; Qiu, Lihua; Qian, Zhengzi; Zhou, Shiyong; Song, Yuqin; Zhang, Qingyuan; Wang, Xianhuo; Zhang, Huilai
2014Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusionZhang, Ping; Tu, Bo; Wang, Hua; Cao, Ziyang; Tang, Ming; Zhang, Chaohua; Gu, Bo; Li, Zhiming; Wang, Lina; Yang, Yang; Zhao, Ying; Wang, Haiying; Luo, Jianyuan; Deng, Chu-Xia; Gao, Bin; Roeder, Robert G.; Zhu, Wei-Guo